News
Videos
Conferences
Events
Resources
Subscribe

|Articles|October 1, 2015

Aziz Nazha Discusses the Future of Treating Patients With MDS

Author(s)Aziz Nazha

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).

Newsletter

Stay up to date on cancer updates, research and education

Related Content

World Cancer Day highlights the global impact of cancer, raising awareness, fostering unity and reminding us to support survivors and patients together: © stock.adobe.com.

Why World Cancer Day Matters to Patients and Survivors

ByFred Batchelor

February 4th 2026

Image of Kasey Keller.

U.S. Soccer Legend Kasey Keller Reveals Lymphoma Journey

February 4th 2026

Image of man.

How Cancer Treatment Affects Lung Function in Survivorship

ByDr. Joshua K. Sabari

February 3rd 2026

Dr. Saad Usmani

What is the Goal of Multiple Myeloma Treatment?

BySaad Usmani, MD

February 3rd 2026

Image of woman.

Doctor Outlines Cervical Cancer Care, Side Effects, HPV Prevention

ByDr. Merieme Klobocista

February 2nd 2026

Trending on CURE

Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us

FDA Grants Priority Review to Datroway for Metastatic Triple-Negative Breast Cancer

U.S. Soccer Legend Kasey Keller Reveals Lymphoma Journey

What is the Goal of Multiple Myeloma Treatment?

FDA Clears Phase 3 Trial of iSCIB1+ for Advanced Melanoma Treatment